Not currently recruiting at UCSF
Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease
Summary
- Eligibility
- for people ages 6 months to 17 years (full criteria)
- Location
- at Brentwood, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Pfizer
- Links
- To obtain contact information for a study center near you, click here.
- ID
- NCT02850406
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 148 study participants
- Last Updated